Michael Schmertzler, Director at PTC THERAPEUTICS, INC. (PTCT), sold 2,500 shares at $59.52 ($149K) on 2026-10-14, disclosed to the SEC on 2026-10-16.
Scheduled sale ($149k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.52 | 2,118 | $126K | 84.6% |
| 2 | $60.14 | 382 | $23K | 15.4% |
| Total | $59.61 avg | 2,500 | $149K | 100% |
| Filing → |
| PTCT | SELL | 2026-09-11 | $1.4M | — | Filing → |
| PTCT | SELL | 2026-08-28 | $1.8M | — | Filing → |
| PTCT | SELL | 2026-08-21 | $1.8M | — | Filing → |